EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Artificial Intelligence and Large Language Models Across the Heart Failure Care Pathway: A Narrative Review

Jack F. Devin, Tyler J. Jones, Eden Powell, Archit Singhal, Morgan E. Evans, Nicholas Gregory, Andrew J. M. Lewis, Oliver J. Rider, Pierre Le Page, John A. Henry, Andrew R. J. Mitchell

Journal of Personalized Medicine · 20.11.2026 · 16 (11) · 583

DOI: 10.3390/jpm16110583 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 20.11.2026. Verfasst von Jack F. Devin und 10 weiteren Autor:innen. Die Arbeit nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure affects more than 64 million people worldwide and remains associated with high mortality and recurrent hospitalisation. Artificial intelligence (AI), including large language models (LLMs), is being evaluated across the care pathway, but evidence maturity varies by task. The aim of this narrative review was to appraise direct evidence for LLM applications in heart failure, distinguish it from supporting evidence for other AI methods and propose a risk-based framework for clinical evaluation and governance. The strongest direct LLM evidence concerns electronic health record extraction, document drafting, patient information and clinical trial endpoint adjudication. A small, randomised pilot evaluated supervised generative-AI-guided optimisation of guideline-directed medical therapy. Prospective case-finding and monitoring evidence largely concerns non-LLM AI. For conversational AI telemonitoring (a natural language interface with rule-based alerting), prospective evidence was limited to a single non-randomised controlled pilot. Performance depends on task definition, data completeness, human review and workflow adoption. Overall, LLMs can support clearly defined, supervised heart failure tasks, but current evidence does not justify autonomous high-stakes care. The evidence base is expanding but predominantly retrospective. Prospective trials, disease-specific benchmarks, equity assessment and regulatory engagement are prerequisites for safe clinical translation. Human oversight remains essential across all current-generation applications.

Zitieren

APA

Devin, J. F., Jones, T. J., Powell, E., Singhal, A., Evans, M. E., Gregory, N., Lewis, A. J. M., Rider, O. J., Page, P. L., Henry, J. A., & Mitchell, A. R. J. (2026). Artificial Intelligence and Large Language Models Across the Heart Failure Care Pathway: A Narrative Review. Journal of Personalized Medicine, 16(11), 583. https://doi.org/10.3390/jpm16110583

Vancouver

Devin JF, Jones TJ, Powell E, Singhal A, Evans ME, Gregory N, et al. Artificial Intelligence and Large Language Models Across the Heart Failure Care Pathway: A Narrative Review. Journal of Personalized Medicine. 2026;16(11):583. doi:10.3390/jpm16110583

BibTeX
@article{Devin2026,
  author = {Devin, Jack F. and Jones, Tyler J. and Powell, Eden and Singhal, Archit and Evans, Morgan E. and Gregory, Nicholas and Lewis, Andrew J. M. and Rider, Oliver J. and Page, Pierre Le and Henry, John A. and Mitchell, Andrew R. J.},
  title = {Artificial Intelligence and Large Language Models Across the Heart Failure Care Pathway: A Narrative Review},
  journal = {Journal of Personalized Medicine},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {583},
  doi = {10.3390/jpm16110583}
}
Kostenlos starten →